Fund Holdings — ARCH Venture Management, LLC

Total Portfolio Value:
$206.22M
Total Bought:
$45.38M
Total Sold:
$3.02M
Net Transaction:
+$42.35M
Notable People:
Robert Taylor Nelsen
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Beam Therapeutics Inc.(BEAM)4,540,1324,540,1320$112.60M$88.67M43.00%-$23.93M
Maze Therapeutics, Inc.(MAZE)04,120,053+4,120,053$0$45.36M22.00%+$45.36M
Rapport Therapeutics, Inc.(RAPP)3,728,7383,728,7380$66.15M$37.55M18.21%-$28.60M
Erasca, Inc.(ERAS)11,055,55411,055,5540$27.75M$15.15M7.34%-$12.60M
Verve Therapeutics, Inc.2,008,8092,008,8090$11.33M$9.12M4.42%-$2.21M
Gossamer Bio, Inc.(GOSS)8,055,9168,055,9160$7.29M$8.78M4.26%+$1.49M
Unity Biotechnology, Inc.1,004,8171,004,8170$981.1K$1.05M0.51%+$63.9K
Q32 Bio Inc.(QTTB)320,482320,4820$1.10M$532.0K0.26%-$570.5K
CERo Therapeutics Holdings, Inc.(CERO)022,102+22,102$0$16.1K0.01%+$16.1K
Singular Genomics Systems, Inc.126,6300-126,630$2.46M$0—-$2.46M
CERo Therapeutics Holdings, Inc.CL A(CERO)9,393,5610-9,393,561$563.6K$0—-$563.6K
Page 1 of 1
ARCH Venture Management, LLC — 13F Holdings — Q1 2025 | TickerTrail